Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up

Autor: Larsen, Trine‐Lise, Garresori, Herish, Brekke, Jorunn, Enden, Tone, Frøen, Hege, Jacobsen, Eva Marie, Quist‐Paulsen, Petter, Porojnicu, Alina Carmen, Ree, Anne Hansen, Torfoss, Dag, Osvik Velle, Elin, Skuterud Wik, Hilde, Ghanima, Waleed, Sandset, Per Morten, Dahm, Anders Erik Astrup ^*

Publikováno v: In Journal of Thrombosis and Haemostasis May 2022 20(5):1166-1181

Bias in animal studies of estrogen effects on cardiovascular disease: A systematic review and meta‐analysis

Autor: Friis Berntsen, Christopher, Rootwelt, Pernille, Dahm, Anders Erik Astrup ^*

Publikováno v: In Research and Practice in Thrombosis and Haemostasis May 2021 5(4)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis

Autor: Frønæs, Synne Grønvold, Dahm, Anders Erik Astrup, Skuterud Wik, Hilde, Jørgensen, Camilla Tøvik, Gleditsch, Jostein, Raouf, Nezar, Holst, René, Klok, Frederikus A., Ghanima, Waleed Khalid

Publikováno v: Frønæs, Synne Grønvold Dahm, Anders Erik Astrup Skuterud Wik, Hilde Jørgensen, Camilla Tøvik Gleditsch, Jostein Raouf, Nezar Holst, René Klok, Frederikus A. Ghanima, Waleed Khalid . Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis. Blood Advances. 2020, 4(11), 2468-2476
Blood Advances

Externí odkaz: http://hdl.handle.net/10852/85522
https://www.duo.uio.no/bitstream/handle/10852/85522/5/advancesadv2020001556.pdf